No evidence for an allelic association between schizophrenia and markers D22S278 and D22S283
β Scribed by Williams, N.M.; Jones, L.A.; Murphy, K.C.; Cardno, A.G.; Asherson, P.; Williams, J.; McGuffin, P.; Owen, M.J.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 68 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
β¦ Synopsis
We report a case control association study using markers D22S278 and D22S283 in 90 unrelated patients with DSMIII-R schizophrenia and 90 controls matched for ethnicity, age and sex. No differences between allele frequencies for either marker were observed when the two groups were compared (D22S278: 2 β«Ψβ¬ 6.53, df β«Ψβ¬ 7, P β«Ψβ¬ 0.51; D22S283: 2 β«Ψβ¬ 14.73, df β«Ψβ¬ 15, P β«Ψβ¬ 0.48). These findings fail to support previous work by others suggesting the presence of allelic association between the markers D22S278 and D22S283 and schizophrenia.
π SIMILAR VOLUMES
There is considerable controversy regarding a putative association between schizophrenia and a biallelic BalI polymorphism in the first exon of the dopamine D3 receptor gene (DRD3), although meta-analyses of published data suggest an association. If such an association exists, it may be detectable a
## Freedman et al. [1997: Proc Natl Acad Sci USA 94:587-592] reported linkage in nine multiplex schizophrenia families to markers on chromosome 15, using impaired neuronal inhibition to repeated auditory stimuli (P50), a neurophysiological deficit associated with schizophrenia, as the phenotype. T